实测钠排泄与CKD进展相关:KNOW-CKD研究结果
该研究在KNOW-CKD前瞻性多中心纵向队列中,纳入G3a至G5期CKD患者1254例,以24小时尿钠排泄量评估膳食盐摄入,分析其与复合肾脏结局(eGFR减半或进展至终末期肾病)的关联。中位随访4.3年,480例(38.7%)发生复合肾脏事件;与Q2参考组(尿钠104.2≤Na<145.1 mEq/天)相比,最高四分位组(尿钠≥192.9 mEq/天)复合肾脏结局风险显著升高(HR 1.8,95%CI 1.12-2.88;P=0.015)。结论:高盐摄入与CKD进展风险增加相关。
要点
- 24小时尿钠≥192.9 mEq/天的CKD G3a-G5患者复合肾脏结局风险增高(HR 1.8)。
- 高盐摄入与肾脏结局的关联在女性、<60岁、未控制高血压及肥胖患者中更明显。
- 膳食盐摄入是CKD进展的可干预因素,但需进一步研究证实限盐获益。
核心结论
- 高盐摄入与CKD患者复合肾脏结局(eGFR减半或ESRD)风险增加相关。
研究设计与样本
- 前瞻性、多中心、纵向KNOW-CKD队列研究,纳入CKD G3a至G5期患者1254例。
- 以24小时尿钠排泄量作为膳食盐摄入标志物,按四分位分组分析。
主要发现
- 中位随访4.3年(IQR 2.8-5.8),480例(38.7%)发生复合肾脏事件。
- 与Q2参考组(尿钠104.2≤Na<145.1 mEq/天)相比,Q4组(尿钠≥192.9 mEq/天)复合肾脏结局风险升高(HR 1.8,95%CI 1.12-2.88;P=0.015)。
- 亚组分析显示高盐摄入与复合肾脏结局的关联在女性、<60岁、未控制高血压及肥胖患者中更显著。
临床怎么用
- 对CKD G3a-G5患者可评估24小时尿钠排泄以识别高盐摄入者。
- 高盐摄入(如尿钠≥192.9 mEq/天)提示肾脏结局风险增高,尤其合并女性、<60岁、未控制高血压或肥胖时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diet is a modifiable factor of chronic kidney disease (CKD) progression. However, the effect of dietary salt intake on CKD progression remains unclear. Therefore, we analyzed the effect of dietary salt intake on renal outcome in Korean patients with CKD. METHODS: We measured 24-h urinary sodium (Na) excretion as a marker of dietary salt intake in the prospective, multi-center, longitudinal KoreaN cohort study for Outcome in patients With CKD (KNOW-CKD). Data were analyzed from CKD patients at Stages G3a to G5 (n = 1254). We investigated the association between dietary salt intake and CKD progression. Patients were divided into four quartiles of dietary salt intake, which was assessed using measured 24-h urinary Na excretion. The study endpoint was composite renal outcome, which was defined as either halving the estimated glomerular filtration rate or developing end-stage renal disease. RESULTS: During a median (interquartile range) follow-up of 4.3 (2.8-5.8) years, 480 (38.7%) patients developed the composite renal event. Compared with the reference group (Q2, urinary Na excretion: 104.2 ≤ Na excretion < 145.1 mEq/day), the highest quartile of measured 24-h urinary Na excretion was associated with risk of composite renal outcome [Q4, urinary Na excretion ≥192.9 mEq/day, hazard ratio 1.8 (95% confidence interval 1.12-2.88); P = 0.015] in a multivariable hazards model. Subgroup analyses showed that high-salt intake was particularly associated with a higher risk of composite renal outcome in women, in patients <60 years of age, in those with uncontrolled hypertension and in those with obesity. CONCLUSIONS: High salt intake was associated with increased risk of progression in CKD.
引用
- Kang M, Kang E, Ryu H, et al. Measured sodium excretion is associated with CKD progression: results from the KNOW-CKD study. Nephrol Dial Transplant. 2021. PMID: 32582942. doi:10.1093/ndt/gfaa107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。